Malaria Clinical Trial
Official title:
Health Impact Evaluation of the "Community-Based Environmental Health Promotion Programme" in Rwanda
Community Health Clubs to improve local sanitation, hygiene and health conditions have been
implemented in several countries in Africa and Asia with some success. The Ministry of Health
in Rwanda has committed to rolling out a program designed along similar lines, the Community
Based Environmental Health Promotion Program (CBEHPP), in all 15000 villages across Rwanda.
The main objective of the program is to achieve 'zero open defecation' in all villages of
Rwanda, at least 80% hygienic latrine coverage and improvements in a range of health
behaviors such as the use of mosquito nets, hand-washing with soap and the use of household
water treatment.
To evaluate the impact of the program on health, other socio-economic outcomes and community
functioning, a single district has been chosen where 150 communities will be randomized to
receive the intervention immediately or 18 months later. The evaluation is led by US based
Innovation for Poverty Action (IPA) through researchers based at the National University of
Rwanda, Georgetown University, London School of Hygiene and Tropical Medicine and New York
University. The research team will work in close collaboration with the implementing team,
which consists of the Ministry of Health, Rwanda and Africa AHEAD.
The study will span three years, beginning in May 2013, and ending in late 2015.
Preventable diseases such as respiratory infections, diarrheal diseases and malaria account
for a large share of mortality in low income economies. For example, diarrheal diseases kill
nearly 2.5 million people worldwide and account for a considerable share of under five
mortality in low income countries. Broad-based economic development that includes
improvements in infrastructure and service delivery can address the challenges associated
with the infectious disease burden. But for many countries, these improvements are far in the
future and/or very costly. Behavior change of individuals can also address these challenges
and more importantly can be done now and relatively cheaply. Understanding how to produce
this behavior change in needy contexts is crucial to the short and medium term response to
the high costs imposed by these diseases. This protocol outlines an evaluation of an
intervention aimed at producing sustainable behavior change around health, hygiene and
sanitation. The evaluation consists of two parts: firstly to evaluate the health and
socio-economic effects of a well-designed and supported community health club intervention.
Secondly to examine whether the intervention can deliver health and other benefits utilizing
the resource base available in this context. The answer to this latter question informs the
scalability of the intervention. The overall objective of the study is to evaluate whether
and how community hygiene/health clubs are an effective and sustainable response to
addressing broad health, sanitation and hygiene needs in low-income countries.
A particular challenge associated with health interventions, is the extent to which
free-rider problems mediate the adoption of improved behaviors. The community health club
approach with regular meetings, is well placed to address these collective action challenges.
Community health clubs provide a vehicle to inform and incentivize households to change their
behavior in relation to a range of health outcomes. The information component arises from the
six month long weekly courses covering a wide range of health, hygiene and sanitary subjects
and facilitated by a community health worker. The incentives for sustainable behavior change
follow from the social sanctions and rewards that club members can impose/bestow on members
accordingly. As with other behavior change programs that have incorporated information
components that emphasize the benefits of better health behavior, the evidence base for what
works in this domain remains thin. The community health club approach is appealing largely
because it mobilizes local resources and is plausibly cheaper and more sustainable than other
top-down interventions.
To evaluate the impact of the program on health, other socio-economic conditions and
community functioning, a single district has been chosen where communities will be randomly
assigned to receive the intervention immediately or 18 months later. The evaluation is led by
US-based Innovation for Poverty Action (IPA) through researchers based at the National
University of Rwanda, Georgetown University, London School of Hygiene and Tropical Medicine
and New York University. The research team will work in close collaboration with the
implementing team, which consists of the Ministry of Health, Rwanda and Africa AHEAD.
The evaluation will measure impact heterogeneity with respect to key inputs that predict
success of CHCs, including training and competence of CHWs, the quality of training
materials, and community functioning. The evaluation will also document in detail the cost
structure of the low- and high-resource versions of CHCs in order to inform the MOH about the
most effective strategies for successful scale up of CHCs nationwide. More broadly, other
governments, donor organizations and foundations will benefit from rigorous evidence on the
effectiveness and cost-effectiveness of using health clubs to address health and sanitation
challenges.
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT04601714 -
Baseline Cohort Malaria Morbidity Study
|
||
Withdrawn |
NCT04020653 -
A Study to Assess the Safety and Efficacy of 5-aminolevulinic Acid Hydrochloride (5-ALA HCl) and Sodium Ferrous Citrate (SFC) Added on Artemisinin-based Combination Therapy (ACT) in Adult Patients With Uncomplicated Malaria
|
Phase 2 | |
Terminated |
NCT04368910 -
Safety and Efficacy of Pyronaridine Artesunate Vs Chloroquine in Children and Adult Patients With Acute Vivax Malaria
|
Phase 3 | |
Completed |
NCT03641339 -
Defining Skin Immunity of a Bite of Key Insect Vectors in Humans
|
N/A | |
Completed |
NCT02544048 -
Markers of T Cell Suppression: Antimalarial Treatment and Vaccine Responses in Healthy Malian Adults
|
||
Completed |
NCT00527163 -
Role of Nitric Oxide in Malaria
|
||
Not yet recruiting |
NCT05934318 -
L-ArGinine to pRevent advErse prEgnancy Outcomes (AGREE)
|
N/A | |
Active, not recruiting |
NCT04704674 -
Community Dynamics of Malaria Transmission in Humans and Mosquitoes in Fleh-la and Marshansue, Salala District, Bong County, Liberia
|
||
Completed |
NCT03276962 -
Efficacy, Safety and Immunogenicity Study of GSK Biologicals' Candidate Malaria Vaccine (SB257049) Evaluating Schedules With or Without Fractional Doses, Early Dose 4 and Yearly Doses, in Children 5-17 Months of Age
|
Phase 2 | |
Completed |
NCT04966871 -
Safety, Tolerability and Efficacy of PfSPZ Vaccine Against Heterologous CHMI in US Malaria naïve Adults
|
Phase 1 | |
Completed |
NCT00289185 -
Study of Safety, Immunogenicity and Efficacy of a Candidate Malaria Vaccine in Tanzanian Infants
|
Phase 2 | |
Recruiting |
NCT03937817 -
Collection of Human Biospecimens for Basic and Clinical Research Into Globin Variants
|
||
Active, not recruiting |
NCT06153862 -
Africa Ready Malaria Screening
|
N/A | |
Completed |
NCT04545905 -
Antenatal Care as a Platform for Malaria Surveillance: Utilizing Community Prevalence Measures From the New Nets Project to Validate ANC Surveillance of Malaria in Burkina Faso
|
||
Recruiting |
NCT06278181 -
Diabetes, Metabolic Syndrome and Risk of Malaria in Cameroon
|
||
Withdrawn |
NCT02793388 -
A Trial on Supervised Primaquine Use in Ethiopia
|
Phase 4 | |
Completed |
NCT02909712 -
Cardiac Safety of Dihydroartemisinin-Piperaquine Amongst Pregnant Women in Tanzania
|
Phase 2 | |
Withdrawn |
NCT02793414 -
Diagnostic Utility of Volatile Organic Compounds in Human Breath for Acute Clinical Malaria in Ethiopia
|
||
Completed |
NCT02793622 -
Prevention of Malaria in HIV-uninfected Pregnant Women and Infants
|
Phase 3 | |
Completed |
NCT02605720 -
Cardiac Safety of Repeated Doses of Dihydroartemisinin-Piperaquine for the Use in Mass Treatment Campaigns
|
Phase 3 |